Regional Oxytocin Changes After THC Did Not Establish a Human Social-Behavior Effect

Repeated THC altered selected oxytocin-related measurements in rat brain regions, but the experiment did not directly establish changes in human bonding, empathy or social behavior.

The study measured expression and staining

Rats received repeated THC, after which researchers assessed oxytocin-neurophysin messenger RNA and oxytocin-related immunoreactivity. The regions included the nucleus accumbens and ventral tegmental area, which participate in reward-related processes.

The timing and regional results differed

The abstract reports reductions after chronic treatment in those regions, without the same early change in the nucleus accumbens at twenty-four hours. It also reports no change in cell staining in two hypothalamic nuclei.

A regional marker cannot represent the whole system

Reduced staining or transcript expression in one region is not equivalent to a measured drop in circulating hormone throughout the body. Messenger RNA and immunoreactivity also provide different information from a direct behavioral assay.

The authors proposed a role in chronic cannabinoid effects based on known oxytocin-related biology. That is a mechanistic suggestion, not a demonstration that the expression changes caused tolerance or withdrawal. The experiment did not test whether an oxytocin treatment would help people using cannabis. Keeping the tissue, timing and measurement explicit prevents an appealing hormone explanation from becoming an unsupported clinical claim.

Related: interpreting cannabis tolerance claims.

Research cited

Butovsky E; Juknat A; Elbaz J; Shabat-Simon M; Eilam R; Zangen A; Altstein M; Vogel Z. Chronic exposure to Delta9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas. Molecular and cellular neurosciences (2006). doi:10.1016/j.mcn.2006.01.008. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Conditioning Accelerated Cannabinoid Tolerance in Female Rats, but a Withdrawal-Like Signal Remained Uncertain

Pairing a drug with an environment accelerated tolerance to HU-210-induced movement suppression in female rats. A later placebo-associated activity increase was only a statistical trend, so it should not be reported as a confirmed withdrawal effect. Associative and nonassociative dosing were compared The experiment used HU-210, a synthetic cannabinoid agonist,…

Spread the love

Read Article: Conditioning Accelerated Cannabinoid Tolerance in Female Rats, but a Withdrawal-Like Signal Remained Uncertain

Cannabinoid Effects on Operant Responding Were More Resistant to Tolerance Than Temperature Effects in Rats

In a rat experiment, tolerance to a synthetic cannabinoid developed most strongly for reduced body temperature and least strongly for suppressed food-reinforced responding. The effects that occurred readily after acute exposure were not necessarily those that adapted fastest. Three tests captured different functions The researchers compared cannabinoid effects on food-reinforced…

Spread the love

Read Article: Cannabinoid Effects on Operant Responding Were More Resistant to Tolerance Than Temperature Effects in Rats

THC-Tolerant Rats Showed Withdrawal-Related Changes Without Greater Morphine Self-Administration

A rat study found behavioral and molecular responses to CB1 blockade after repeated THC exposure, but no increase in morphine self-administration. The withdrawal-related findings and the null reinforcement result answer different questions and should be reported together. An antagonist precipitated the challenge Researchers administered SR141716 to THC-tolerant and control rats….

Spread the love

Read Article: THC-Tolerant Rats Showed Withdrawal-Related Changes Without Greater Morphine Self-Administration

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us